Related Experiment Videos
[Cost/benefit relations in heart transplantation]
H H Scheld1, M C Deng, D Hammel
1Klinik und Poliklinik für Thorax-, Herz- und Gefässchirurgie, Westfälische Wilhelms-Universität, Münster.
Insights
Cardiac transplantation is costly, with an estimated 55,000 DM per year of life gained. To optimize outcomes and manage healthcare costs, specialized centers, multicenter trials, and societal discussion on resource allocation are crucial.
Area of Science:
- Cardiology
- Health Economics
- Transplantation Medicine
Context:
- The increasing use of cardiac transplantation and mechanical/antiarrhythmic bridging necessitates an economic evaluation.
- Current therapeutic modalities present significant financial implications for healthcare systems.
Purpose:
- To critically assess the economic impact of cardiac transplantation and associated bridging therapies.
- To identify key considerations for optimizing the cost-effectiveness and ethical implementation of cardiac replacement strategies.
Summary:
- Cardiac transplantation incurs substantial costs, estimated at 55,000 DM per year of life gained, with limited immediate cost recovery even with high reintegration rates.
- Recommendations include centralizing transplantation in experienced centers, conducting multicenter trials for cost-saving strategies, enhancing professional reintegration programs, and emphasizing ethical considerations.
- Societal input is vital for resource allocation decisions, and a primary preventive approach for coronary artery disease is essential given its role in transplant candidacy.
Impact:
- Highlights the need for specialized centers of excellence for cardiac transplantation to ensure comprehensive patient care and efficient resource utilization.
- Underscores the importance of collaborative multicenter research to develop and validate cost-effective therapeutic strategies in transplantation.
- Emphasizes the ethical imperative and societal responsibility in determining resource allocation for advanced cardiac therapies and the integration of preventive cardiology.
Abstract:
The expanding role of cardiac transplantation as well as mechanical and antiarrhythmic bridging requires a critical reflection of the economic impact of these therapeutic modalities. Based on assumptions from the pertinent literature, cardiac transplantation requires costs of about 55,000 DM per year of life gained by the procedure. Even if a maximum social and professional reintegration percentage of about 60% is assumed, it does not seem possible to perform the procedure without additional costs to the health care system. The consequences of this are the following: 1) Cardiac transplantation should only be performed by centers experienced in all aspects of terminal heart failure care including a heart failure program, high-risk conventional surgery program, mechanical and antiarrhythmia bridging program, and qualified post transplant care program. 2) In order to evaluate potentially cost-saving therapeutic strategies in cardiac transplantation, multicenter trials have to be conducted which require a continuous scientific working group and research data organization based on the consensus of all participating transplant centers. 3) An improved professional reintegration program is necessary. 4) The ethical foundation for offering cardiac replacement to patients, namely, the responsibility for the individual person's well-being, has to be emphasized by physicians active in the field. 5) The society as a whole, not the group of physicians active in the field, has to debate and decide on how many resources should be spent in this field of health care. 6) Since potential cardiac transplant recipients are, to a large extent, recruited from patients suffering from coronary artery disease, it is essential to incorporate a primary preventive perspective into this high-technology field of medicine.